Physician profile
Leon Hendley
NPI 1043213291
$9,720.86
in general payments reported to CMS, 2019-2025
41 companies · $670 in 2025
The $670 reported for 2025 was more than what a typical Cardiovascular Disease provider received nationally (typical 2025 total: $433).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,463 · 2020: $884 · 2021: $1,249 · 2022: $1,606 · 2023: $2,402 · 2024: $1,447 · 2025: $670.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $3,968 · Travel and Lodging: $406 · Education: $145.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $3,967.50 |
| Travel and Lodging | $405.67 |
| Education | $144.98 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novartis Pharmaceuticals Corporation | $1,173.45 | 2019-2025 | |
| Boston Scientific Corporation | $823.88 | 2019-2025 | Watchman Access System, Watchman Flx, Resonate El Icd Vr |
| Pfizer INC. | $674.78 | 2019-2025 | |
| Bayer Healthcare Pharmaceuticals INC. | $670.32 | 2021-2025 | |
| Astrazeneca Pharmaceuticals Lp | $665.04 | 2019-2025 | Brilinta, Andexxa, Farxiga |
| Janssen Pharmaceuticals, INC | $517.20 | 2019-2024 | Xarelto |
| Boehringer Ingelheim Pharmaceuticals, INC. | $516.14 | 2019-2023 | Jardiance |
| Abbott Laboratories | $442.38 | 2021-2025 | Mitraclip, Amplatzer Amulet |
| Amarin Pharma, INC. | $386.68 | 2019-2020 | |
| E.R. Squibb & Sons, L.L.C. | $381.71 | 2019-2025 | Camzyos, Eliquis |
| Sanofi-Aventis U.S. LLC | $367.45 | 2019-2023 | |
| Esperion Therapeutics, INC. | $331.27 | 2020-2025 | Nexletol |
| Kowa Pharmaceuticals America, INC. | $322.41 | 2019-2022 | |
| Alnylam Pharmaceuticals INC. | $286.37 | 2019-2024 | Amvuttra, Onpattro |
| Cvrx, INC. | $259.72 | 2023-2025 | Barostim Neo System |
Show all 41 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Leon Hendley listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.